NEWS CENTER
SCROLL
Dec 29, 2023
29/ 12
Rona Therapeutics's First Self-developed siRNA Product has been Approved for Conducting Clinical Trial in China
Nov 12, 2023
12/ 11
Rona Therapeutics Participated in the 2023 Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) and Published Novel ApoC3 siRNA Preclinical Results
May 15, 2023
15/ 05
Rona Therapeutics and Keymed Biosciences Announce Collaboration to Discover and Develop First-in-class siRNA Therapeutics for Glomerulonephritis
Jan 12, 2023
12/ 01
EnnovaBio Pharmaceuticals and Rona Therapeutics Announce Collaboration to Discover First-in-class siRNA Therapeutics to Treat Liver Diseases
Apr 07, 2022
07/ 04
Rona Therapeutics Announces Completion of $33 Million Series A Financing to Advance Global Discovery and Development of RNA Therapeutics
EXPLORER MORE
Jinyu Huang, Ph.D.
Chief Executive Officer, Founder
Stella Shi is founder, Chief Executive Officer and chairs the board of Rona Therapeutics since company inception in 2021 bringing ~15 years of biopharmaceutical industry and venture capital experience. Prior to founding Rona Therapeutics, Stella was managing director in Lilly Asia Ventures (LAV) from 2015 with proven track records with various venture creation ...